Emmanuel Hui

Mr. Emmanuel Andrew Hui is a biomedical entrepreneur and investor with a decade-long track record spanning clinical care, scientific innovation, and venture capital. Starting as an EMT while completing his Senior Fellowship in Chemistry at Dartmouth College, he went on to co-found Moogene Medi, a gene therapy company now listed on the Korean stock exchange (322970.KS). After listing, he returned to Hong Kong to join Sagamore Investments, managing a portfolio of over 2,000 companies in China private equity. In 2021, he founded the Tiger Jade Pebble Accelerator (“Pebble”), a company dedicated to i.) incubating and investing in Hong Kong biotech startups, ii.) bringing global innovations into China, and iii.) bringing Chinese innovations to the world through Hong Kong. Pebble is backed by Tigermed, China’s largest clinical CRO and other major institutions such as Morningside and Nan Fung. Through Pebble, he has done multiple deals and projects with Saltagen, and he officially joined Salta